492 related articles for article (PubMed ID: 26522484)
1. Gestational trophoblastic diseases - clinical guidelines for diagnosis, treatment, follow-up, and counselling.
Niemann I; Vejerslev LO; Frøding L; Blaakær J; Maroun LL; Hansen ES; Grove A; Lund H; Havsteen H; Sunde L
Dan Med J; 2015 Nov; 62(11):A5082. PubMed ID: 26522484
[TBL] [Abstract][Full Text] [Related]
2. A Case of Rapid Transformation from Hydatidiform Mole to Invasive Mole: The Importance of β-hCG (Human Chorionic Gonadotropin) Serum Levels in Follow-Up Evaluation.
Harsono AB; Hidayat YM; Winarno GNA; Nisa AS; Alkaff FF
Am J Case Rep; 2021 Jun; 22():e931156. PubMed ID: 34127641
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the viability of trophoblast after termination of various kinds of pregnancies (author's transl)].
Kanda K
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1575-82. PubMed ID: 6263995
[TBL] [Abstract][Full Text] [Related]
4. [Use of sulprostone in the evacuation of molar pregnancies].
Pinet C; Colau JC
Rev Fr Gynecol Obstet; 1991 Jan; 86(1):53-5. PubMed ID: 2068488
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of remission in trophoblastic disease as seen from serum hCG level (author's transl)].
Hirashima N
Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):592-600. PubMed ID: 6263999
[TBL] [Abstract][Full Text] [Related]
6. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
Tscherne G; Pürstner P
Geburtshilfe Frauenheilkd; 1979 Aug; 39(8):704-8. PubMed ID: 478273
[TBL] [Abstract][Full Text] [Related]
7. An analysis of the influences of maternal age, gestational age, contraceptive method, and the mode of primary treatment of patients with hydatidiform moles on the incidence of subsequent chemotherapy.
Stone M; Bagshawe KD
Br J Obstet Gynaecol; 1979 Oct; 86(10):782-92. PubMed ID: 228696
[TBL] [Abstract][Full Text] [Related]
8. Gestational trophoblastic diseases: the ratio of choriogonadotropin to specific pregnancy protein, hCG/SP1, provides useful diagnostic and prognostic evidence.
Szymendera JJ; Ploch E; Zalucka K; Sikorowa L; Kaminska JA; Gadek A
Gynecol Oncol; 1986 Feb; 23(2):149-59. PubMed ID: 3002918
[TBL] [Abstract][Full Text] [Related]
9. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
Zhang WY; Yen GL
Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of the malignant form of trophoblastic disease after a hydatidiform mole: systematic or selective chemotherapy].
Delvoye P; Robyn C
J Gynecol Obstet Biol Reprod (Paris); 1975 Mar; 4(2):267-93. PubMed ID: 181422
[TBL] [Abstract][Full Text] [Related]
11. Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole.
Bagshawe KD; Lawler SD; Paradinas FJ; Dent J; Brown P; Boxer GM
Lancet; 1990 May; 335(8697):1074-6. PubMed ID: 1970378
[TBL] [Abstract][Full Text] [Related]
12. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
Asmar FTC; Braga-Neto AR; de Rezende-Filho J; Villas-Boas JMS; Charry RC; Maesta I
Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
[TBL] [Abstract][Full Text] [Related]
13. Inhibin: a new circulating marker of hydatidiform mole?
Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
Fan C; Goto S; Furuhashi Y; Tomoda Y
J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
[TBL] [Abstract][Full Text] [Related]
15. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center.
Lurain JR; Brewer JI; Torok EE; Halpern B
Obstet Gynecol; 1982 Sep; 60(3):354-60. PubMed ID: 6289207
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotropin and its subunits in hydatidiform mole and choriocarcinoma.
Dawood MY; Saxena BB; Landesman R
Obstet Gynecol; 1977 Aug; 50(2):172-81. PubMed ID: 195242
[TBL] [Abstract][Full Text] [Related]
17. Asian approaches in the treatment of trophoblastic disease.
Teoh ES
Obstet Gynecol Clin North Am; 1988 Sep; 15(3):545-64. PubMed ID: 2852334
[TBL] [Abstract][Full Text] [Related]
18. Hydatidiform mole and gestational trophoblastic disease in Southern Connecticut.
Kohorn EI
Obstet Gynecol; 1982 Jan; 59(1):78-84. PubMed ID: 6281702
[TBL] [Abstract][Full Text] [Related]
19. [On the results of hydatidiform mole managed by Niigata method].
Hando T; Kodama S; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Dec; 37(12):2722-30. PubMed ID: 4086902
[TBL] [Abstract][Full Text] [Related]
20. The clinical evaluation of the simultaneous measurements of human chorionic gonadotropin (hCG) and its alpha-subunit in sera of patients with trophoblastic diseases.
Nishimura R; Ashitaka Y; Tojo S
Endocrinol Jpn; 1979 Oct; 26(5):575-83. PubMed ID: 527560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
